Plexus (NASDAQ:PLXS) Stock Rating Reaffirmed by Benchmark

Plexus (NASDAQ:PLXS)‘s stock had its “buy” rating reiterated by Benchmark in a research note issued on Monday, Benzinga reports. They presently have a $150.00 target price on the technology company’s stock. Benchmark’s target price would suggest a potential upside of 11.29% from the company’s current price.

Separately, Needham & Company LLC boosted their price objective on shares of Plexus from $114.00 to $144.00 and gave the stock a “buy” rating in a report on Friday, July 26th. Three equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Plexus has an average rating of “Hold” and an average price target of $125.25.

Plexus Stock Down 1.1 %

Shares of NASDAQ PLXS opened at $134.78 on Monday. The firm has a fifty day moving average of $129.74 and a 200-day moving average of $115.48. The company has a quick ratio of 0.64, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Plexus has a 52-week low of $87.21 and a 52-week high of $139.98. The stock has a market capitalization of $3.67 billion, a PE ratio of 33.95 and a beta of 0.89.

Plexus (NASDAQ:PLXS) last announced its quarterly earnings results on Wednesday, July 24th. The technology company reported $1.45 earnings per share for the quarter, topping analysts’ consensus estimates of $1.28 by $0.17. Plexus had a net margin of 2.82% and a return on equity of 9.64%. The firm had revenue of $960.70 million during the quarter, compared to analysts’ expectations of $981.32 million. During the same period in the prior year, the company earned $1.32 EPS. The firm’s revenue was down 6.0% on a year-over-year basis. On average, analysts anticipate that Plexus will post 3.74 EPS for the current year.

Insiders Place Their Bets

In other Plexus news, CEO Todd P. Kelsey sold 3,000 shares of the business’s stock in a transaction on Wednesday, July 31st. The shares were sold at an average price of $128.40, for a total value of $385,200.00. Following the transaction, the chief executive officer now owns 93,682 shares in the company, valued at $12,028,768.80. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In other news, insider Steven J. Frisch sold 6,565 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $128.11, for a total value of $841,042.15. Following the sale, the insider now owns 36,118 shares in the company, valued at approximately $4,627,076.98. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Todd P. Kelsey sold 3,000 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $128.40, for a total transaction of $385,200.00. Following the completion of the sale, the chief executive officer now owns 93,682 shares in the company, valued at approximately $12,028,768.80. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 20,113 shares of company stock worth $2,541,394 in the last quarter. 2.39% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Plexus

A number of institutional investors have recently modified their holdings of the stock. Riverwater Partners LLC raised its stake in shares of Plexus by 132.2% in the 3rd quarter. Riverwater Partners LLC now owns 18,850 shares of the technology company’s stock valued at $2,545,000 after purchasing an additional 10,731 shares in the last quarter. Schaper Benz & Wise Investment Counsel Inc. WI raised its stake in shares of Plexus by 62.6% in the 3rd quarter. Schaper Benz & Wise Investment Counsel Inc. WI now owns 13,346 shares of the technology company’s stock valued at $1,825,000 after purchasing an additional 5,138 shares in the last quarter. Trust Point Inc. acquired a new stake in shares of Plexus in the 3rd quarter valued at about $208,000. nVerses Capital LLC acquired a new stake in shares of Plexus in the 3rd quarter valued at about $178,000. Finally, Creative Planning raised its stake in shares of Plexus by 56.0% in the 3rd quarter. Creative Planning now owns 14,616 shares of the technology company’s stock valued at $1,998,000 after purchasing an additional 5,245 shares in the last quarter. Institutional investors and hedge funds own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.